A61K 39/0008
Antigens related to auto-immune diseases
Official title: {Antigens related to auto-immune diseases; Preparations to induce self-tolerance}
A61K39/0008 (Antigens related to auto-immune diseases) appears on 795 US grants and 1,614 published applications in this corpus.
Search patents in A61K- Granted patents
- 795
- Published applications
- 1,614
- Assignees
- 641
- Inventors
- 2,088
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 7 | 0 |
| 1997 | 11 | 0 |
| 1998 | 14 | 0 |
| 1999 | 16 | 0 |
| 2000 | 13 | 0 |
| 2001 | 9 | 3 |
| 2002 | 19 | 46 |
| 2003 | 5 | 46 |
| 2004 | 6 | 46 |
| 2005 | 5 | 43 |
| 2006 | 19 | 52 |
| 2007 | 9 | 47 |
| 2008 | 14 | 37 |
| 2009 | 14 | 48 |
| 2010 | 20 | 53 |
| 2011 | 34 | 54 |
| 2012 | 16 | 68 |
| 2013 | 25 | 65 |
| 2014 | 36 | 54 |
| 2015 | 27 | 76 |
| 2016 | 45 | 73 |
| 2017 | 38 | 94 |
| 2018 | 47 | 97 |
| 2019 | 48 | 88 |
| 2020 | 43 | 71 |
| 2021 | 46 | 77 |
| 2022 | 46 | 90 |
| 2023 | 31 | 80 |
| 2024 | 44 | 90 |
| 2025 | 40 | 78 |
| 2026 | 25 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Suppression of diabetes using exosomes from stem cell programmed myeloid cells22 Sep 2026US 12,741,015 B2Creative Medical Technologies, Inc.
- C-terminus modified human papilloma virus type 6 L1 protein and use thereof22 Sep 2026US 12,741,016 B2Chinese Academy of Medical Sciences
- Recombinant protein capable of resisting multiple sclerosis and preparation method and application thereof15 Sep 2026US 12,734,224 B2Institute of Zoology, Guangdong Academy of Sciences
- Compositions and methods for inducing immune tolerance8 Sep 2026US 12,728,155 B2Anokion SA
- Production of MHC II/CII complexes1 Sep 2026US 12,721,884 B2
- Preparation of tolerizing nanoparticles for the treatment of primary biliary cholangitis8 Oct 2026US 2026/0306598 A1Cour Pharmaceuticals Development Company, Inc.
- Microbial consortium and uses thereof24 Sep 2026US 2026/0284125 A1The Regents of the University of California
- Tolerizing immune modifying nanoparticles for myasthenia gravis treatment24 Sep 2026US 2026/0284161 A1Cour Pharmaceuticals Development Company, Inc.
- Peptide conjugated particles24 Sep 2026US 2026/0284162 A1Northwestern University
- Methods and compositions for the treatment of autoimmune and inflammatory diseases17 Sep 2026US 2026/0274992 A1Lankenau Institute for Medical Research
Most cited
By later US patents
- Compositions and methods for delivery of genetic material132US 5,962,428 AApollon Inc. · 1999
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- Method of treating or preventing type 1 diabetes by oral administration of insulin125US 5,763,396 AAutoimmune, Inc. · 1998
- Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens124US 5,994,126 AThe Rockefeller University · 1999
- Composition for inducing proliferation or accumulation of regulatory T cells98US 9,808,519 B2The University of Tokyo · 2017